AMOXICILLIN AND CLAVULANATE POTASSIUM

Product NDC: 81964-203
11-digit product format: 819640203
Labeler code: 81964
Product ID: 81964-203_52497cef-6663-3e6f-e063-6394a90a35ee
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: amoxicillin and clavulanate potassium
Dosage form: FOR SUSPENSION
Route: ORAL
Labeler: USAntibiotics, LLC
Application: NDA050755
Marketing category: NDA AUTHORIZED GENERIC
Marketing start: 2022-09-19
Substance: AMOXICILLIN; CLAVULANATE POTASSIUM
Active strength: 600; 42.9 mg/5mL; mg/5mL
Pharmacologic classes: Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N050755-001	AUGMENTIN ES-600	AMOXICILLIN; CLAVULANATE POTASSIUM	600MG/5ML;EQ 42.9MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	2001-06-22

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
N050755-001	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N050755-001	AUGMENTIN ES-600	600MG/5ML;EQ 42.9MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	2001-06-22	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N050755-001	AUGMENTIN ES-600	600MG/5ML;EQ 42.9MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	2001-06-22	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N050755-001	AUGMENTIN ES-600	600MG/5ML;EQ 42.9MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	2001-06-22	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N050755-001	AUGMENTIN ES-600	600MG/5ML;EQ 42.9MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	2001-06-22	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N050755-001	AUGMENTIN ES-600	600MG/5ML;EQ 42.9MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	2001-06-22	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N050755-001	AUGMENTIN ES-600	600MG/5ML;EQ 42.9MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	2001-06-22	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N050755-001	AUGMENTIN ES-600	600MG/5ML;EQ 42.9MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	2001-06-22	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N050755-001	AUGMENTIN ES-600	600MG/5ML;EQ 42.9MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	2001-06-22	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N050755-001	AUGMENTIN ES-600	600MG/5ML;EQ 42.9MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	2001-06-22	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N050755-001	AUGMENTIN ES-600	600MG/5ML;EQ 42.9MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	2001-06-22	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N050755-001	AUGMENTIN ES-600	600MG/5ML;EQ 42.9MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	2001-06-22	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N050755-001	AUGMENTIN ES-600	600MG/5ML;EQ 42.9MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	2001-06-22	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N050755-001	AUGMENTIN ES-600	600MG/5ML;EQ 42.9MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	2001-06-22	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N050755-001	AUGMENTIN ES-600	600MG/5ML;EQ 42.9MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	2001-06-22	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N050755-001	AUGMENTIN ES-600	600MG/5ML;EQ 42.9MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	2001-06-22	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N050755-001	AUGMENTIN ES-600	600MG/5ML;EQ 42.9MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	2001-06-22	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N050755-001	AUGMENTIN ES-600	600MG/5ML;EQ 42.9MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	2001-06-22	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N050755-001	AUGMENTIN ES-600	600MG/5ML;EQ 42.9MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	2001-06-22	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N050755-001	AUGMENTIN ES-600	600MG/5ML;EQ 42.9MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	2001-06-22	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N050755-001	AUGMENTIN ES-600	600MG/5ML;EQ 42.9MG BASE/5ML	FOR SUSPENSION / ORAL		RLD	2001-06-22	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N050755-001	AUGMENTIN ES-600	600MG/5ML;EQ 42.9MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	2001-06-22	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N050755-001	AUGMENTIN ES-600	600MG/5ML;EQ 42.9MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	2001-06-22	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N050755-001	AUGMENTIN ES-600	600MG/5ML;EQ 42.9MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	2001-06-22	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N050755-001	AUGMENTIN ES-600	600MG/5ML;EQ 42.9MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	2001-06-22	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N050755-001	AUGMENTIN ES-600	600MG/5ML;EQ 42.9MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	2001-06-22	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N050755-001	AUGMENTIN ES-600	600MG/5ML;EQ 42.9MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	2001-06-22	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N050755-001	AUGMENTIN ES-600	600MG/5ML;EQ 42.9MG BASE/5ML	FOR SUSPENSION / ORAL		RLD	2001-06-22	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N050755-001	AUGMENTIN ES-600	600MG/5ML;EQ 42.9MG BASE/5ML	FOR SUSPENSION / ORAL		RLD	2001-06-22	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N050755-001	AUGMENTIN ES-600	600MG/5ML;EQ 42.9MG BASE/5ML	FOR SUSPENSION / ORAL		RLD	2001-06-22	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N050755-001	AUGMENTIN ES-600	600MG/5ML;EQ 42.9MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	2001-06-22	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N050755-001	AUGMENTIN ES-600	600MG/5ML;EQ 42.9MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	2001-06-22	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N050755-001	AUGMENTIN ES-600	600MG/5ML;EQ 42.9MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	2001-06-22	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N050755-001	AUGMENTIN ES-600	600MG/5ML;EQ 42.9MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	2001-06-22	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N050755-001	AUGMENTIN ES-600	600MG/5ML;EQ 42.9MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	2001-06-22	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N050755-001	AUGMENTIN ES-600	600MG/5ML;EQ 42.9MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	2001-06-22	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N050755-001	AUGMENTIN ES-600	600MG/5ML;EQ 42.9MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	2001-06-22	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N050755-001	AUGMENTIN ES-600	600MG/5ML;EQ 42.9MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	2001-06-22	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N050755-001	AUGMENTIN ES-600	600MG/5ML;EQ 42.9MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	2001-06-22	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N050755-001	AUGMENTIN ES-600	600MG/5ML;EQ 42.9MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	2001-06-22	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N050755-001	AUGMENTIN ES-600	600MG/5ML;EQ 42.9MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	2001-06-22	`f41ea6bd6efb…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-09-14 22:38:34	2026-08	N050755-001	AB	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N050755-001	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N050755-001	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N050755-001	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N050755-001	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N050755-001	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N050755-001	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N050755-001	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N050755-001	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N050755-001	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N050755-001	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N050755-001	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N050755-001	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N050755-001	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N050755-001	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N050755-001	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N050755-001	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N050755-001	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N050755-001	AB	1	`4b0b4de00fa7…`
2022-03-09 01:35 UTC	2022-03	N050755-001	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N050755-001	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N050755-001	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N050755-001	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N050755-001	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N050755-001	AB	1	`c0c555d07b60…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N050755-001	AB	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N050755-001	AB	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N050755-001	AB	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N050755-001	AB	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N050755-001	AB	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N050755-001	AB	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N050755-001	AB	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N050755-001	AB	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N050755-001	AB	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N050755-001	AB	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N050755-001	AB	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N050755-001	AB	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N050755-001	AB	1	`cb3db0bc1861…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N050755-001	AB	1	`a50c72e98297…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: AMOXICILLIN AND CLAVULANATE POTASSIUM
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
AMOXICILLIN	600 mg/5mL
CLAVULANATE POTASSIUM	42.9 mg/5mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
804826J2HU	Internal UNII lookup
Q42OMW3AT8	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
617993	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
7d4dfd6f-bd1a-4acc-8506-07fca08f8a38	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
502415e5-4ac7-4266-a01a-ef44aa3c028d	Product name	7	20250623
d0f377c9-74d8-e2e3-e06e-4d37534f5c0f	Product name	3	20250620
2ebbc361-d28f-48a9-a286-c1ae09cdaf5c	Product name	3	20230314
2bb254ff-3d7f-4bdb-abf9-476506008c55	Product name	1	20230117
f33561b9-47cb-411c-a228-16c62e346cd4	Product name	1	20200415
8690a824-4bf8-4d1e-b118-2d6dda86bc04	Product name	2	20161206
cf3f1c02-1f32-2322-3314-b70ebbf5610e	Product name	1	20140508
ebb3e917-326a-9e18-0354-a19c9f63a2f3	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
81964-203-51	AMOXICILLIN AND CLAVULANATE POTASSIUM	75 mL in 1 BOTTLE	FOR SUSPENSION	75	5
81964-203-54	AMOXICILLIN AND CLAVULANATE POTASSIUM	200 mL in 1 BOTTLE	FOR SUSPENSION	200	5
81964-203-69	AMOXICILLIN AND CLAVULANATE POTASSIUM	125 mL in 1 BOTTLE	FOR SUSPENSION	125	5

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
81964-203-51	ML - Milliliter	81964-203	4ddaaf1c-0011-418c-ac2f-20e31f53e55a	1	2022-11-07
81964-203-54	ML - Milliliter	81964-203	efca6360-a191-438b-a7fc-56b21ddc1ce3	1	2022-11-07
81964-203-69	ML - Milliliter	81964-203	cbfaa09d-475a-4907-90c3-7bffc26909e9	1	2022-11-07

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
81964-203	AMOXICILLIN AND CLAVULANATE POTASSIUM FOR SUSPENSION [USANTIBIOTICS, LLC ]	3	Current NDC, Legacy NDC, 3 package rows	20240518_7d4dfd6f-bd1a-4acc-8506-07fca08f8a38.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
AMOXICILLIN AND CLAVULANATE POTASSIUM	AMOXICILLIN AND CLAVULANATE POTASSIUM	USAntibiotics, LLC	7d4dfd6f-bd1a-4acc-8506-07fca08f8a38	2026-07-07	Warnings, Adverse reactions	Exact identifier application applno (NDA): 050755 application number: NDA050755 ndc (product): 81964-203
AUGMENTIN ES-600	AMOXICILLIN AND CLAVULANATE POTASSIUM	USAntibiotics, LLC	59979859-8c9b-4173-a5e3-2e6312fd9d79	2026-07-07	Warnings, Adverse reactions	Exact identifier application applno (NDA): 050755 application number: NDA050755
AMOXICILLIN AND CLAVULANATE POTASSIUM	AMOXICILLIN AND CLAVULANATE POTASSIUM	Redpharm Drug	2fbb57ba-08d8-0224-e063-6294a90ab683	2025-12-30	Warnings, Adverse reactions	Exact identifier application applno (NDA): 050755 application number: NDA050755
AMOXICILLIN AND CLAVULANATE POTASSIUM	AMOXICILLIN AND CLAVULANATE POTASSIUM	NuCare Pharmaceuticals, Inc.	2bb03d3b-5d44-bc4a-e063-6394a90a656a	2025-01-14	Warnings, Adverse reactions	Exact identifier application applno (NDA): 050755 application number: NDA050755

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
804826J2HU	AMOXICILLIN	61336-70-7	AMOXICILLIN
Q42OMW3AT8	CLAVULANATE POTASSIUM	61177-45-5	CLAVULANATE POTASSIUM

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
617993	amoxicillin 600 MG / clavulanic acid 42.9 MG in 5 mL Oral Suspension	PSN	7d4dfd6f-bd1a-4acc-8506-07fca08f8a38	5
617993	amoxicillin 120 MG/ML / clavulanate 8.58 MG/ML Oral Suspension	SCD	7d4dfd6f-bd1a-4acc-8506-07fca08f8a38	5
617993	amoxicillin (as amoxicillin trihydrate) 600 MG / clavulanic acid (as clavulanate potassium) 42.9 MG per 5 ML Oral Suspension	SY	7d4dfd6f-bd1a-4acc-8506-07fca08f8a38	5
617993	amoxicillin 600 MG / clavulanic acid 42.9 MG per 5 ML Oral Suspension	SY	7d4dfd6f-bd1a-4acc-8506-07fca08f8a38	5
617993	amoxicillin 600 MG / clavulanic acid 42.9 MG in 5 mL Oral Suspension	PSN	2fbb57ba-08d8-0224-e063-6294a90ab683	3
617993	amoxicillin 120 MG/ML / clavulanate 8.58 MG/ML Oral Suspension	SCD	2fbb57ba-08d8-0224-e063-6294a90ab683	3
617993	amoxicillin (as amoxicillin trihydrate) 600 MG / clavulanic acid (as clavulanate potassium) 42.9 MG per 5 ML Oral Suspension	SY	2fbb57ba-08d8-0224-e063-6294a90ab683	3
617993	amoxicillin 600 MG / clavulanic acid 42.9 MG per 5 ML Oral Suspension	SY	2fbb57ba-08d8-0224-e063-6294a90ab683	3
617993	amoxicillin 600 MG / clavulanic acid 42.9 MG in 5 mL Oral Suspension	PSN	2bb03d3b-5d44-bc4a-e063-6394a90a656a	1
617993	amoxicillin 120 MG/ML / clavulanate 8.58 MG/ML Oral Suspension	SCD	2bb03d3b-5d44-bc4a-e063-6394a90a656a	1
617993	amoxicillin (as amoxicillin trihydrate) 600 MG / clavulanic acid (as clavulanate potassium) 42.9 MG per 5 ML Oral Suspension	SY	2bb03d3b-5d44-bc4a-e063-6394a90a656a	1
617993	amoxicillin 600 MG / clavulanic acid 42.9 MG per 5 ML Oral Suspension	SY	2bb03d3b-5d44-bc4a-e063-6394a90a656a	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
81964-203-51	81964020351	75 mL in 1 BOTTLE (81964-203-51)	75 ml	2022-09-19	0000-00-00	No	No	Current
81964-203-54	81964020354	200 mL in 1 BOTTLE (81964-203-54)	200 ml	2022-09-19	0000-00-00	No	No	Current
81964-203-69	81964020369	125 mL in 1 BOTTLE (81964-203-69)	125 ml	2022-09-19	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
AMOXICILLIN AND CLAVULANATE POTASSIUM	USAntibiotics, LLC	2026-07-07	HUMAN PRESCRIPTION DRUG LABEL	6
AMOXICILLIN AND CLAVULANATE POTASSIUM	Redpharm Drug	2025-12-30	HUMAN PRESCRIPTION DRUG LABEL	3
AMOXICILLIN AND CLAVULANATE POTASSIUM	NuCare Pharmaceuticals, Inc.	2025-01-14	HUMAN PRESCRIPTION DRUG LABEL	1
AMOXICILLIN AND CLAVULANATE POTASSIUM	RPK Pharmaceuticals, Inc.	2024-12-19	HUMAN PRESCRIPTION DRUG LABEL	2